Insights - BIO

Areas of Work

	New Senate Biosimilars Proposal Would Jeopardize New Medical Advancements and Cures Jul 8 2009 WASHINGTON, D.C. (Wednesday, July 08, 2009) - The following statement was issued today by the Biotechnology Industry Organization (BIO) regarding a proposal to establish a pathway for regulatory...
	Temporary PTO Funding Option is Critical For Biotech Innovation and Jobs Jul 8 2009 ...
	Climate Change: Are New Policies an Opportunity or Barrier to the Biofuel, Renewable Chemicals Industries? Jul 7 2009 WASHINGTON, D.C. (Tuesday, July 07, 2009) - Pending climate change legislation and regulations for the Renewable Fuel Standard are creating an uncertain environment for investment in advanced...
	BIO Commends NIH on New Stem Cell Research Guidelines Jul 7 2009 WASHINGTON, D.C. (Tuesday, July 07, 2009) - The Biotechnology Industry Organization released the following statement in response to the National Institutes of Health’s (NIH) final guidelines on...
	U.S. Farmers Prefer Biotech Varieties of Corn, Cotton, Soybeans Jul 1 2009 WASHINGTON, D.C. (Wednesday, July 01, 2009) - American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996, especially corn, cotton and soybean varieties,...
	BIO Comments on White House Letter on Biosimilars Jun 25 2009 WASHINGTON, D.C. (Thursday, June 25, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the letter sent yesterday from the...
	BIO Comments On Medicare Drug Discount Agreement Announced by PhRMA, the White House and Senate Finance Committee Jun 22 2009 WASHINGTON, D.C. (Monday, June 22, 2009) - The following statement was issued today by the Biotechnology Industry Organization (BIO) regarding the agreement reached among the Obama administration,...
	BIO Commends Selection of Kappos to Lead PTO Jun 19 2009 WASHINGTON, D.C. (Friday, June 19, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today in response to President Obama’s nomination...
	BIO Commends Senate Committee on Small Business and Entrepreneurship’s SBIR Reauthorization Jun 18 2009 WASHINGTON, D.C. (Thursday, June 18, 2009) - Under legislation reported today by the Senate Committee on Small Business and Entrepreneurship, small companies that receive the majority of their...
	AARP Biologics Study Based on Fuzzy Math, Flawed Assumptions Jun 11 2009 WASHINGTON, D.C. (Thursday, June 11, 2009) - The following statement was issued by the Biotechnology Industry Organization (BIO) regarding a study on biosimilars presented to Congressional staff...